- Home
- NTRA vs NI Comparison
NTRA vs NI Comparison
Compare NTRA & NI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRA
- NI
- Stock Information
- Founded
- NTRA 2003
- NI 1912
- Country
- NTRA United States
- NI United States
- Employees
- NTRA N/A
- NI N/A
- Industry
- NTRA Medical Specialities
- NI Power Generation
- Sector
- NTRA Health Care
- NI Utilities
- Exchange
- NTRA Nasdaq
- NI Nasdaq
- Market Cap
- NTRA 27.0B
- NI 20.1B
- IPO Year
- NTRA 2015
- NI N/A
- Fundamental
- Price
- NTRA $207.56
- NI $43.73
- Analyst Decision
- NTRA Strong Buy
- NI Buy
- Analyst Count
- NTRA 18
- NI 9
- Target Price
- NTRA $208.94
- NI $46.00
- AVG Volume (30 Days)
- NTRA 1.3M
- NI 4.7M
- Earning Date
- NTRA 11-06-2025
- NI 10-29-2025
- Dividend Yield
- NTRA N/A
- NI 2.56%
- EPS Growth
- NTRA N/A
- NI 15.58
- EPS
- NTRA N/A
- NI 1.90
- Revenue
- NTRA $2,116,676,000.00
- NI $6,327,100,000.00
- Revenue This Year
- NTRA $25.70
- NI $17.50
- Revenue Next Year
- NTRA $15.42
- NI $4.02
- P/E Ratio
- NTRA N/A
- NI $23.08
- Revenue Growth
- NTRA 38.17
- NI 19.62
- 52 Week Low
- NTRA $125.38
- NI $35.36
- 52 Week High
- NTRA $210.77
- NI $44.88
- Technical
- Relative Strength Index (RSI)
- NTRA 76.32
- NI 58.25
- Support Level
- NTRA $182.20
- NI $42.06
- Resistance Level
- NTRA $210.90
- NI $42.92
- Average True Range (ATR)
- NTRA 7.80
- NI 0.95
- MACD
- NTRA 0.69
- NI 0.03
- Stochastic Oscillator
- NTRA 88.43
- NI 66.37
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
About NI NiSource Inc
NiSource is one of the nation's largest natural gas distribution companies with 3.2 million customers in Indiana, Kentucky, Maryland, Ohio, Pennsylvania, and Virginia. NiSource's electric utility transmits and distributes electricity in northern Indiana to about 500,000 customers. The regulated electric utility also owns more than 3,000 megawatts of generation capacity, including coal, natural gas, and renewable energy.